NASDAQ: NAOV - NanoVibronix, Inc.

Altı ay boyunca karlılık: -44%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı NanoVibronix, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında NanoVibronix, Inc.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.

daha fazla ayrıntı
The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2017-06-27
ISIN US63008J1088
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nanovibronix.com
Цена ао 3.89
Günlük fiyat değişimi: -3.58% (3.91)
Haftalık fiyat değişimi: -14.12% (4.39)
Aylık fiyat değişimi: +5.42% (3.5761)
3 ayda fiyat değişimi: -40.93% (6.3822)
Altı ayda fiyat değişimi: -44% (6.732)
Yıllık fiyat değişimi: +318.89% (0.9)
3 yılda fiyat değişimi: +314.51% (0.9095)
5 yılda fiyat değişimi: +35.74% (2.7774)
Yılbaşından bu yana fiyat değişimi: -42.83% (6.5945)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0.7896 9
P/BV 0.452 10
P/E 0 0
EV/EBITDA 0.4295 10
Toplam: 6.13

Yeterlik

İsim Anlam Seviye
ROA, % -55.6 0
ROE, % -93.05 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0015 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 330.75 10
karlılık Ebitda, % -38.66 0
karlılık EPS, % -87.3 0
Toplam: 2
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Renaissance Technologies, LLC 41200 1.48
Vanguard Group Inc 30194 1.08
Geode Capital Management, LLC 14461 0.52
Amtrust Financial Services, Inc. 12408 0.45
Tower Research Capital LLC (TRC) 5262 0.19
UBS Group AG 3537 0.13
National Bank of Canada/FI 110 0
Blackrock Inc. 74 0
Wells Fargo & Company 13 0
Morgan Stanley 10 0



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Brian M. Murphy CEO & Director 382.5k 1957 (68 yıllar)
Mr. Stephen R. Brown CPA Chief Financial Officer 292.5k 1956 (69 yıllar)
Dr. Harold Jacob M.D. Chief Medical Officer & Director N/A 1954 (71 yıl)
Mr. Amir Rippel Vice President of Marketing N/A
Ms. Lindsey Harrison Vice President of Sales N/A

Adres: United States, Elmsford. NY, 525 Executive Boulevard - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.nanovibronix.com